Isolation, identification, and characterization of cancer stem cells: A review

J Cell Physiol. 2017 Aug;232(8):2008-2018. doi: 10.1002/jcp.25759. Epub 2017 Feb 28.

Abstract

Cancer stem cells (CSCs) or tumor-initiating cells (TICs) as a small subset of neoplastic cells are able to produce a tumor (tumorigenesis), maintain the population of tumorigenic cells (self-renewal), and generate the heterogeneous cells constructing the entire tumor (pluripotency). The research on stationary and circulating CSCs due to resistance to conventional therapies and inability in complete eradication of cancer is critical for developing novel therapeutic strategies for a more effective reduction in the risk of tumor metastasis and cancer recurrence. This review compiles information about different methods of detection and dissociation, side population, cellular markers, and establishment culture of CSCs, as well as characteristics of CSCs such as tumorigenicity, and signaling pathways associated with self-renewal and the capability of the same histological tumor regeneration in various cancers.

Keywords: cancer stem cells; cellular markers; self-renewal; side population; sphere; tumorigenicity.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use
  • Biomarkers, Tumor / metabolism
  • Cell Movement
  • Cell Self Renewal
  • Cell Separation / methods*
  • Drug Resistance, Neoplasm
  • Humans
  • Neoplasm Metastasis
  • Neoplasms / drug therapy
  • Neoplasms / metabolism
  • Neoplasms / pathology*
  • Neoplastic Cells, Circulating / drug effects
  • Neoplastic Cells, Circulating / metabolism
  • Neoplastic Cells, Circulating / pathology*
  • Neoplastic Stem Cells / drug effects
  • Neoplastic Stem Cells / metabolism
  • Neoplastic Stem Cells / pathology*
  • Phenotype
  • Side-Population Cells / drug effects
  • Side-Population Cells / metabolism
  • Side-Population Cells / pathology*
  • Signal Transduction
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor